During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed treatment for a patient with chronic ...

A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter ...

Researchers have determined how children's immune systems react to different kinds of cancer depending on their age. The study reveals significant differences between the immune response of children ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Objectives SLE is a multifaceted autoimmune disorder with a complex pathogenesis involving genetic, environmental and ...

Every 40 seconds, someone in the United States has a stroke. For survivors of the most common type of stroke, called an ischemic stroke, only about 5 percent fully recover.

A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...

PhaseV, a leader in software and machine learning (ML) for advanced clinical development optimization, today announced it has ...

Cutaneous lupus erythematosus (CLE) is associated with an increased risk for atherosclerotic cardiovascular disease ...

Genes: Experts believe there is a link between specific genes and the likelihood of developing some types of arthritis such ...